Transforming Real-World Assets into Scalable Growth Opportunities
Table of Contents
- Executive Summary 1.
- The Problem & Solution 2.
- Why Silk Fibroin? 3.
- Market Opportunity & Industry Overview 4.
- Business Model & Project Overview 5.
- Investment Breakdown & RWA Pool Concept 6.
- Financial Roadmap 7.
- Competitive Advantage & Competitor Analysis 8.
- ESG Compatibility 9.
- Team & Partnerships 10.
- Risk Mitigation & Case Studies 11.
- Roadmap & Call to Action 12.
Executive Summary
Investment Required
Target funding in RMB
Time to Market
From setup to full operation
Target Exit Value
Projected IPO valuation in USD
Strategic Vision
Establish a state-of-the-art silk fibroin production line for the beauty, health, and wellness sectors
Strategic Location
Based in Guangzhou Nansha, China, positioning us at the heart of manufacturing excellence
Implementation Plan
4-6 months initial setup phase with clear path to market readiness
The Problem
Growing demand for sustainable, high-quality raw materials in beauty and health
Limited scalable production of silk fibroin worldwide
Consumers increasingly seek ESG-compliant options
The Solution
Versatile and Sustainable Protein
Silk fibroin as a versatile, sustainable protein for numerous applications
Patented Production Line
Patented, ESG-compliant production line supported by government incentives
Streamlined Supply Chain
Streamlined supply chain ensuring consistency, quality, and scalability
Why Silk Fibroin?
Biocompatible and Sustainable
Silk fibroin is a biocompatible, sustainable, and premium-quality material. Its unique properties make it an ideal choice for various applications.
Proven Market Demand
There is proven demand for silk fibroin, as seen in existing competitor success. This demonstrates the material's market potential and consumer interest.
ESG and Sustainability Alignment
Silk fibroin shows strong alignment with global ESG and sustainability standards. This makes it an attractive option for environmentally conscious businesses and consumers.
Market Opportunity
Growing Global Market
Strong projected CAGR for the global silk fibroin market, indicating significant expansion and investment potential in this sector.
Beauty & Cosmetics Leadership
Established billion-dollar beauty and cosmetics industry driving demand for silk fibroin, particularly in skincare and cosmetic applications.
Emerging Sectors
Additional growth opportunities in health and wellness, nutraceuticals, and biomedical applications, expanding market potential beyond cosmetics.
Industry Overview
Our target markets represent significant opportunities across multiple sectors:
Cosmetics Industry
Valued at billions with continuous expansion, demonstrating substantial market potential for innovative beauty and personal care solutions.
Nutraceutical Sector
Positioned for robust growth, bridging nutrition and pharmaceuticals with increasing consumer interest and market demand.
Biomedical Applications
Showing sustained CAGR in tissue engineering and regenerative medicine, indicating expanding opportunities for advanced healthcare technologies.
Business Model
OEM Contracts with Beauty Brands
Strategic partnerships with established beauty brands to manufacture custom formulations.
B2B Raw Material Supply
High-quality materials supplied directly to manufacturers for diverse applications.
Direct-to-Consumer Sales
E-commerce platform offering finished products to end consumers.
Target Markets
Focused expansion across Beauty, FMCG, Health & Wellness, and R&D sectors.
Project Overview
- 1,500 sqm facility in Nansha, Guangzhou
- 4–6 months to establish production line and secure certifications
- Government grants and incentives accelerating entry and differentiation
Investment Breakdown
Total Required: RMB 33M
Investment Allocation
CAPEX
Primary facility investment
OPEX & Marketing
Operational expenses
Miscellaneous
Additional costs
Funding Sources Distribution
PLM Malaysia acts as lead investor with strategic partnership from China Biotech
RWA Pool Concept
Initial Phase
Minimum phase-based contribution in RMB
Small Lot Entry
Starting investment size in RMB
Asset-Backed Security
Investment pools backed by silk fibroin production
Flexible Investment
Multiple contribution levels from RMB 2,500 to 10,000
Dual Returns
Benefits through product distribution and dividend payments
Financial Roadmap
Our financial journey is structured in clear phases leading to a targeted IPO.
Year 1: Foundation
Setup facilities and initial silk fibroin production
Years 2-3: Scale & Growth
Expanding operations and driving revenue growth
Year 4: IPO Target
IPO at P.E. 20, targeting USD 150M valuation
This strategic progression allows us to build a strong foundation, scale effectively, and reach our public offering goals in a systematic manner.
Competitive Advantage
Our company possesses several key competitive advantages that position us uniquely in the market:
• Strategic partnerships with government bodies, UnionPay, Bitney Community, and SEA distributors
• Patented processes, certifications, and ESG compliance
• Exclusive market reach in Southeast Asia
Competitor Analysis
Benchmark: Dr. Serum (Japan)
- Established market presence in Japan
- USD 40M monthly sales volume
Differentiation
- Superior ESG compliance and certification
- Broader applications
- Diversified revenue streams
ESG Compatibility
Environmental
Sustainable raw materials and eco-friendly production
Social
Job creation and community development in Nansha
Governance
Transparent financial and operational practices
Team & Partnerships
Our success is built on world-class expertise and strategic collaborations.
Core Team
Expert team combining biotech, marketing, and operational excellence
中科国思 (China Biotech)
Strategic biotech research and development partnership
Financial Partners
Integration with UnionPay and Bitney Community ecosystem
Distribution Network
Strategic partnerships across Southeast Asia
Risk Mitigation
Operational Risks
Operational risks minimized by government support and stable supply chain
Market Risks
Market risks offset by diversified revenue streams
Financial Risks
Financial risks reduced through phased funding and transparency
Case Studies & Validation
Premium Beauty Success
Demonstrated market success with high-end beauty products featuring silk fibroin as a key ingredient
Partner Validation
Strong endorsements from early-stage partners and initial investors confirming market potential
Roadmap
Phase 1 (Months 0–6)
Factory setup
Phase 2 (Year 1–2)
Initial production and scaling
Phase 3 (Year 3)
Market penetration and revenue growth
Phase 4 (Year 4)
IPO preparation
Be Part of Our Thriving Community
Don't miss this extraordinary opportunity to be part of our transformative journey in the silk fibroin industry.
Limited Early-Stage Opportunity
Secure your position at the ground floor of a revolutionary biotech venture with massive growth potential.
Clear Path to Returns
Strategic IPO exit plan with established milestones and transparent timeline.
Time-Sensitive Opportunity
Early investor benefits available only for a limited time as we move rapidly towards production phase.
Ready to take the next step? Contact us today to secure your position in this groundbreaking opportunity.
📧 Contact us: [Contact Information]
Silk Fibroin Production Line